CA2802203A1 - Compositions and methods of treating no-option critical limb ischemia (cli) - Google Patents

Compositions and methods of treating no-option critical limb ischemia (cli) Download PDF

Info

Publication number
CA2802203A1
CA2802203A1 CA2802203A CA2802203A CA2802203A1 CA 2802203 A1 CA2802203 A1 CA 2802203A1 CA 2802203 A CA2802203 A CA 2802203A CA 2802203 A CA2802203 A CA 2802203A CA 2802203 A1 CA2802203 A1 CA 2802203A1
Authority
CA
Canada
Prior art keywords
cells
composition
subject
amputation
cli
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2802203A
Other languages
English (en)
French (fr)
Inventor
Ronnda Bartel
Sharon Watling
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vericel Corp
Original Assignee
Aastrom Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aastrom Biosciences Inc filed Critical Aastrom Biosciences Inc
Publication of CA2802203A1 publication Critical patent/CA2802203A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA2802203A 2010-06-10 2011-06-10 Compositions and methods of treating no-option critical limb ischemia (cli) Abandoned CA2802203A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35351210P 2010-06-10 2010-06-10
US61/353,512 2010-06-10
PCT/US2011/040087 WO2011156784A1 (en) 2010-06-10 2011-06-10 Compositions and methods of treating no-option critical limb ischemia (cli)

Publications (1)

Publication Number Publication Date
CA2802203A1 true CA2802203A1 (en) 2011-12-15

Family

ID=44246418

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2802203A Abandoned CA2802203A1 (en) 2010-06-10 2011-06-10 Compositions and methods of treating no-option critical limb ischemia (cli)

Country Status (6)

Country Link
US (1) US20120100108A1 (https=)
EP (1) EP2579882A1 (https=)
JP (1) JP2013528230A (https=)
AU (1) AU2011265194A1 (https=)
CA (1) CA2802203A1 (https=)
WO (1) WO2011156784A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140099292A1 (en) * 2012-03-23 2014-04-10 Aastrom Biosciences, Inc. CD14+ Cell Compositions and Methods of Using Same
CA2868032A1 (en) * 2012-03-23 2013-09-26 Aastrom Biosciences, Inc. Cell compositions and methods of using same
US20150064141A1 (en) 2012-04-05 2015-03-05 The Regents Of The University Of California Regenerative sera cells and mesenchymal stem cells
WO2014089397A1 (en) * 2012-12-06 2014-06-12 Aastrom Biosciences, Inc. Compositions and methods of treating and preventing pulmonary fibrosis
US10331856B1 (en) * 2012-12-19 2019-06-25 One Call Care Management Physical therapy patient treatment monitoring systems and methods
WO2016140716A1 (en) 2015-03-02 2016-09-09 The Trustees Of Columbia University In The City Of New York Injectable microtissue systems, devices, and methods
CN107949390A (zh) * 2015-05-01 2018-04-20 赛斯卡医疗有限公司 用于治疗的自体骨髓的肌内施用
US10456423B2 (en) 2016-06-13 2019-10-29 SMART SURGICAL, Inc. Compositions for biological systems and methods for preparing and using the same
US10426796B2 (en) * 2016-06-13 2019-10-01 SMART SURGICAL, Inc. Compositions for biological systems and methods for preparing and using the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070023302A1 (en) 2005-07-29 2007-02-01 Nationalpak Limited Watch box with back-up effective security locker and warranty compartment
US9598673B2 (en) * 2006-05-19 2017-03-21 Creative Medical Health Treatment of disc degenerative disease
CA2913024A1 (en) 2006-11-03 2008-05-08 Aastrom Biosciences, Inc. Mixed cell populations for tissue repair and separation technique for cell processing

Also Published As

Publication number Publication date
WO2011156784A1 (en) 2011-12-15
AU2011265194A1 (en) 2013-01-10
US20120100108A1 (en) 2012-04-26
EP2579882A1 (en) 2013-04-17
JP2013528230A (ja) 2013-07-08

Similar Documents

Publication Publication Date Title
US20120100108A1 (en) Compositions and methods of treating no-option critical limb ischemia (cli)
EP3546570A2 (en) Serum-free immune cell-culturing medium-added kit, method for culturing immune cells by using same kit, serum-free immune cell culture obtained by same kit or culturing method, and cosmetic composition comprising same culture
JP2011529706A (ja) 間充織間質細胞集団、ならびにそれを単離および使用する方法
JP6622189B2 (ja) 疼痛及び／又は線維症の調節において脂肪組織由来細胞を使用する方法
JP2015159895A (ja) 脳梗塞治療のための多能性幹細胞
US11738046B2 (en) Macrophage cell therapy to treat orthopedic injury
AU2017202192A1 (en) Mesenchymal Stromal Cell Populations and Methods of Making Same
JP2023060299A (ja) 敗血症の治療のための、ワルトンジェリーから取得された間葉系幹細胞
CN114901806B (zh) 细胞群以及其取得方法
AU2012255112A1 (en) Mesenchymal stromal cell populations and methods of making same
WO2014089397A1 (en) Compositions and methods of treating and preventing pulmonary fibrosis
JP7591564B2 (ja) 変形性関節症を治療するための治療用アポトーシス細胞
US20210154230A1 (en) Intradiscal t-regulatory cell administration for treatment of disc degenerative disease
JP2021531279A (ja) 自然リンパ系細胞による小膠細胞活性化の抑制
JP2018111722A (ja) 脳梗塞治療のための多能性幹細胞
WO2024133886A1 (en) Primed mesenchymal stem cells for use in the treatment of chronic kidney disease
HK40072852A (en) Therapeutic apoptotic cells for treatment of osteoarthritis
HK40072852B (zh) 用於治疗骨关节炎的治疗性凋亡细胞
Pittenger et al. Immunological properties of mesenchymal stem cells isolated from bone marrow and umbilical cord
Van Rooijen Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20170612